vs

Side-by-side financial comparison of Outset Medical, Inc. (OM) and Star Equity Holdings, Inc. (STRR). Click either name above to swap in a different company.

Star Equity Holdings, Inc. is the larger business by last-quarter revenue ($56.8M vs $28.9M, roughly 2.0× Outset Medical, Inc.). Star Equity Holdings, Inc. runs the higher net margin — -3.0% vs -67.5%, a 64.5% gap on every dollar of revenue. On growth, Star Equity Holdings, Inc. posted the faster year-over-year revenue change (69.0% vs -2.0%). Star Equity Holdings, Inc. produced more free cash flow last quarter ($-9.0M vs $-9.7M). Over the past eight quarters, Star Equity Holdings, Inc.'s revenue compounded faster (29.5% CAGR vs 1.2%).

Outset Medical, Inc. is a medical technology company focused on developing and commercializing innovative dialysis solutions for patients living with kidney disease. Its flagship Tablo Hemodialysis System supports use in acute care facilities, outpatient clinics, and home settings, serving healthcare providers and patients across the U.S. and select international markets.

Artists Equity is an American production company founded by actors and filmmakers Ben Affleck and Matt Damon in November 2022.

OM vs STRR — Head-to-Head

Bigger by revenue
STRR
STRR
2.0× larger
STRR
$56.8M
$28.9M
OM
Growing faster (revenue YoY)
STRR
STRR
+71.0% gap
STRR
69.0%
-2.0%
OM
Higher net margin
STRR
STRR
64.5% more per $
STRR
-3.0%
-67.5%
OM
More free cash flow
STRR
STRR
$786.0K more FCF
STRR
$-9.0M
$-9.7M
OM
Faster 2-yr revenue CAGR
STRR
STRR
Annualised
STRR
29.5%
1.2%
OM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
OM
OM
STRR
STRR
Revenue
$28.9M
$56.8M
Net Profit
$-19.5M
$-1.7M
Gross Margin
42.4%
Operating Margin
-61.1%
-0.2%
Net Margin
-67.5%
-3.0%
Revenue YoY
-2.0%
69.0%
Net Profit YoY
24.0%
-192.1%
EPS (diluted)
$0.33
$-0.49

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OM
OM
STRR
STRR
Q4 25
$28.9M
$56.8M
Q3 25
$29.4M
$48.0M
Q2 25
$31.4M
$35.5M
Q1 25
$29.8M
$31.9M
Q4 24
$29.5M
$33.6M
Q3 24
$28.7M
$36.9M
Q2 24
$27.4M
$35.7M
Q1 24
$28.2M
$33.9M
Net Profit
OM
OM
STRR
STRR
Q4 25
$-19.5M
$-1.7M
Q3 25
$-17.8M
$-1.8M
Q2 25
$-18.5M
$-688.0K
Q1 25
$-25.8M
$-1.8M
Q4 24
$-25.6M
$-585.0K
Q3 24
$-27.9M
$-846.0K
Q2 24
$-34.5M
$-441.0K
Q1 24
$-39.9M
$-2.9M
Gross Margin
OM
OM
STRR
STRR
Q4 25
42.4%
Q3 25
39.4%
43.0%
Q2 25
37.8%
Q1 25
37.2%
Q4 24
36.5%
Q3 24
34.3%
50.5%
Q2 24
35.7%
Q1 24
29.2%
Operating Margin
OM
OM
STRR
STRR
Q4 25
-61.1%
-0.2%
Q3 25
-53.7%
-3.4%
Q2 25
-53.7%
-0.6%
Q1 25
-55.1%
-5.4%
Q4 24
-74.2%
-0.4%
Q3 24
-83.2%
-1.2%
Q2 24
-112.3%
-0.5%
Q1 24
-131.0%
-9.0%
Net Margin
OM
OM
STRR
STRR
Q4 25
-67.5%
-3.0%
Q3 25
-60.6%
-3.7%
Q2 25
-59.0%
-1.9%
Q1 25
-86.7%
-5.5%
Q4 24
-87.0%
-1.7%
Q3 24
-97.5%
-2.3%
Q2 24
-125.8%
-1.2%
Q1 24
-141.8%
-8.6%
EPS (diluted)
OM
OM
STRR
STRR
Q4 25
$0.33
$-0.49
Q3 25
$-1.00
$-0.54
Q2 25
$-1.04
$-0.23
Q1 25
$-3.66
$-0.59
Q4 24
$-7.21
$-0.21
Q3 24
$-8.02
$-0.28
Q2 24
$-9.96
$-0.15
Q1 24
$-11.77
$-0.95

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OM
OM
STRR
STRR
Cash + ST InvestmentsLiquidity on hand
$168.9M
$10.3M
Total DebtLower is stronger
$96.2M
Stockholders' EquityBook value
$127.0M
$65.7M
Total Assets
$264.5M
$113.2M
Debt / EquityLower = less leverage
0.76×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OM
OM
STRR
STRR
Q4 25
$168.9M
$10.3M
Q3 25
$178.6M
$15.4M
Q2 25
$184.1M
$16.8M
Q1 25
$189.0M
$16.6M
Q4 24
$158.7M
$17.0M
Q3 24
$175.6M
$15.8M
Q2 24
$194.8M
$14.7M
Q1 24
$226.9M
$20.4M
Total Debt
OM
OM
STRR
STRR
Q4 25
$96.2M
Q3 25
$6.5M
Q2 25
Q1 25
Q4 24
$197.4M
$0
Q3 24
Q2 24
Q1 24
Stockholders' Equity
OM
OM
STRR
STRR
Q4 25
$127.0M
$65.7M
Q3 25
$142.4M
$67.8M
Q2 25
$154.8M
$40.1M
Q1 25
$169.9M
$39.5M
Q4 24
$26.8M
$40.4M
Q3 24
$47.8M
$42.9M
Q2 24
$68.6M
$42.6M
Q1 24
$93.2M
$44.3M
Total Assets
OM
OM
STRR
STRR
Q4 25
$264.5M
$113.2M
Q3 25
$277.3M
$117.1M
Q2 25
$288.8M
$55.6M
Q1 25
$301.2M
$53.2M
Q4 24
$275.8M
$52.6M
Q3 24
$292.9M
$52.6M
Q2 24
$314.5M
$52.6M
Q1 24
$346.2M
$52.6M
Debt / Equity
OM
OM
STRR
STRR
Q4 25
0.76×
Q3 25
0.10×
Q2 25
Q1 25
Q4 24
7.36×
0.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OM
OM
STRR
STRR
Operating Cash FlowLast quarter
$-9.5M
$-7.3M
Free Cash FlowOCF − Capex
$-9.7M
$-9.0M
FCF MarginFCF / Revenue
-33.7%
-15.8%
Capex IntensityCapex / Revenue
0.8%
3.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-47.1M
$-13.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OM
OM
STRR
STRR
Q4 25
$-9.5M
$-7.3M
Q3 25
$-6.3M
$-2.7M
Q2 25
$-4.8M
$139.0K
Q1 25
$-25.7M
$-802.0K
Q4 24
$-16.5M
$-2.8M
Q3 24
$-20.6M
$1.3M
Q2 24
$-33.3M
$-4.3M
Q1 24
$-45.9M
$-1.8M
Free Cash Flow
OM
OM
STRR
STRR
Q4 25
$-9.7M
$-9.0M
Q3 25
$-6.5M
$-3.4M
Q2 25
$-5.1M
$102.0K
Q1 25
$-25.8M
$-808.0K
Q4 24
$-16.5M
$-2.8M
Q3 24
$-21.0M
$1.3M
Q2 24
$-33.5M
$-4.3M
Q1 24
$-46.3M
$-1.8M
FCF Margin
OM
OM
STRR
STRR
Q4 25
-33.7%
-15.8%
Q3 25
-22.0%
-7.0%
Q2 25
-16.3%
0.3%
Q1 25
-86.7%
-2.5%
Q4 24
-56.1%
-8.3%
Q3 24
-73.1%
3.4%
Q2 24
-122.2%
-12.0%
Q1 24
-164.3%
-5.3%
Capex Intensity
OM
OM
STRR
STRR
Q4 25
0.8%
3.0%
Q3 25
0.5%
1.3%
Q2 25
0.9%
0.1%
Q1 25
0.4%
0.0%
Q4 24
0.1%
0.1%
Q3 24
1.4%
0.0%
Q2 24
0.4%
0.0%
Q1 24
1.3%
0.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OM
OM

Consumables Product$13.5M47%
Service And Other Revenue$9.0M31%
Consoles Product$6.4M22%

STRR
STRR

Revenue From Other Contracts With Customers$27.6M49%
Other$24.3M43%
Energy Services Segment$4.9M9%

Related Comparisons